NEPHMICRO

Nephros, Inc.

HealthcareMedical - Instruments & Supplies
$3.24
$0.00(-0.92%)
52W$2.66
$6.42
Updated Jun 29, 02:00 AM
RSI48
RS Rating29/99
Beta0.86
Volatility93%
F-Score6/9
Mkt Cap$35M
DOWNTREND

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

DOWNTREND

Nephros, Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 29), showing significant lag compared to the market leaders. Earnings contraction of 76% provides fundamental context to the price action. Investors should exercise caution due to high volatility (93% annualized), which requires wider risk management.

Relative Strength
29
out of 99
Lagging
Trend Score
0/4
Minervini Criteria
DOWNTREND
Risk (Beta)
0.86
vs S&P 500
DEFENSIVE
52W Position
15%
from 52W low
Near Low
Trend & Momentum Analysis

Trend Template (Minervini)

DOWNTREND0/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$3.29
50 SMA > 100 SMA$3.39
100 SMA > 150 SMA$3.90
150 SMA > 200 SMA$4.14

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$3.35-3.24%BELOW
50 SMA$3.29-1.50%BELOW
100 SMA$3.39-4.50%BELOW
150 SMA$3.90-16.83%BELOW
200 SMA$4.14-21.79%BELOW

Price Performance

1D-0.9%
1W-0.6%
1M-9.5%
3M+10.2%
6M-34.3%
YTD-31.8%
1Y-23.6%
3Y+26.3%
52-Week Trading Range15% from low
$3.24
52W Low$2.66
52W High$6.42

Technical Indicators

RSI (14)NEUTRAL
48.4
305070
Setup ScoreCOOL
4/10
Base depth: 36.6%

Risk Profile

Beta
0.86
52W Vol
93%
ATR
$0.20
Max DD (1Y)
-52%

Volume Analysis

Today
17.1K
50D Avg
23.7K
Vol Ratio
0.72x
Liquidity
ILLIQUID

Earnings Momentum

Q2'25+180%
$0.02
Q3'25+76%
$0.03
Q4'25-83%
$0.01
Q1'26-76%
$0.01
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:+25.46%
5 Years:+17.02%
3 Years:+23.50%
TTM:+23.25%

Compounded Profit Growth

10 Years:
5 Years:
3 Years:
TTM:-6.49%

Stock Price CAGR

10 Years:+3.31%
5 Years:-19.17%
3 Years:+26.25%
1 Year:-23.58%

Return on Equity

10Y Avg:-50.4%
5Y Avg:-18.9%
3Y Avg:-1.6%
Last Year:7.7%

Key Metrics

Market Cap$35M
Gross Margin61.1%
Net Margin6.4%
Piotroski F-Score6/9

Frequently Asked Questions

Is NEPH in an uptrend right now?

NEPH has a trend score of 0/4 based on Minervini's Stage Analysis. Currently showing broken structure - 0 of 4 trend criteria are met.

Is NEPH overbought or oversold?

NEPH's RSI (14) is 48. The stock is in neutral territory, neither overbought nor oversold.

Is NEPH outperforming the market?

NEPH has a Relative Strength (RS) Rating of 29 out of 99. NEPH is currently lagging the broader market.

Where is NEPH in its 52-week range?

NEPH is trading at $3.24, which is 50% of its 52-week high ($6.42) and 15% above its 52-week low ($2.66).

How volatile is NEPH?

NEPH has a Beta of 0.86 and 52-week volatility of 93%. It's less volatile than the S&P 500 - generally more stable.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.